90273-30-6

Usage

Uses

Used in Pharmaceutical Industry:
5-METHYL-1-BENZOTHIOPHENE-2-SULFONYL CHLORIDE is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to create biologically active molecules.
Used in Agrochemical Industry:
5-METHYL-1-BENZOTHIOPHENE-2-SULFONYL CHLORIDE is used as a building block in the development of agrochemicals, contributing to the creation of effective compounds for agricultural applications.
Used in Materials Science:
5-METHYL-1-BENZOTHIOPHENE-2-SULFONYL CHLORIDE is used as a component in the research and development of new materials, thanks to its potential applications in materials science.
Used in Organic Electronic Devices:
5-METHYL-1-BENZOTHIOPHENE-2-SULFONYL CHLORIDE is used as a constituent in the development of organic electronic devices, leveraging its unique properties for innovative technological advancements.

InChI:InChI=1/C9H7ClO2S2/c1-6-2-3-8-7(4-6)5-9(13-8)14(10,11)12/h2-5H,1H3

Relevant academic research and scientific papers

Substituted sulfonic acid N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds

The compounds of formula I exhibit useful pharmacological activity and accordingly are incorporated into pharmaceutical compositions and used in the treatment of patients suffering from certain medical disorders. More specifically, they are inhibitors of the activity of Factor Xa. The present invention is directed to compounds of formula I, compositions containing compounds of formula I, and their use, which are for treating a patient suffering from, or subject to, physiological condition which can be ameliorated by the administration of an inhibitor of the activity of Factor Xa.

SUBSTITUTED SULFONIC ACID N-[(AMINOIMINOMETHYL)PHENYLALKYL]-AZAHETEROCYCLAMIDE COMPOUNDS

The compounds of formula I exhibit useful pharmacological activity and accordingly are incorporated into pharmaceutical compositions and used in the treatment of patients suffering from certain medical disorders. More specifically, they are inhibitors of the activity of Factor Xa. The present invention is directed to compounds of formula I, compositions containing compounds of formula I, and their use, which are for treating a patient suffering from, or subject to, physiological condition which can be ameliorated by the administration of an inhibitor of the activity of Factor Xa.